FDA NDC Directory · JSON-LD · Markdown

Deferoxamine mesylate

NDC 60505-6236 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA207384
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsDEFEROXAMINE MESYLATE (500 mg/1)
Marketing started20211105
Package count1

External sources

Source: openFDA. Public-domain (CC0).